XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.0.1
Subsequent Events
12 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
Subsequent Events [Text Block]

NOTE 7: SUBSEQUENT EVENTS

 

The Company has evaluated all events that occur after the balance sheet date through March 13, 2025, the date when the financial statements were available to be issued, to determine if they must be reported. Management of the Company determined that there are no material subsequent events to be disclosed other than those described below.

 

Subsequent to December 31, 2024 the Company purchased $230,443 worth of inventory from related party entities owned and controlled by the Company’s members of management and board of directors. Additionally, the Company received $36,735 worth of advances from related party entities owned and controlled by the Company’s members of management and the board of directors to pay for operating expenses and the Company used their overpayment of $21,798 and cash of $295,000 to make repayments on the advances.

 

Effective February 21, 2025, the Nowtransit board approved a resolution to change the name of the company to BioScience Health Innovations, Inc and filed the necessary documents with the Nevada Secretary of State.